Related Experiment Video

Updated: Aug 20, 2026

Isolation of Double Negative αβ T Cells from the Kidney
06:56

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity

Maureen A McGargill1, Ben G Wen, Craig M Walsh

  • 1Division of Biological Sciences, Department of Cellular and Molecular Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 USA.

Immunity
|December 14, 2004
PubMed

Insights

Mice lacking DRAK2 (death-associated protein kinase 2) showed T cells that activate more easily but were resistant to autoimmune disease. DRAK2 regulates T cell activation thresholds, impacting autoimmune responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • DRAK2 is a serine/threonine kinase in the DAP-like family, known to induce apoptosis.
  • DRAK2 is specifically expressed in T cells and B cells and is regulated during T cell development.

Purpose of the Study:

  • To investigate the role of DRAK2 in lymphocyte apoptosis and T cell activation.
  • To determine if DRAK2 deficiency impacts T cell receptor (TCR)-mediated signaling and autoimmune disease development.

Main Methods:

  • Generation and analysis of Drak2 knockout (Drak2(-/-)) mice.
  • Assessment of T cell apoptosis, negative selection, and TCR-mediated stimulation.
  • Evaluation of experimental autoimmune encephalomyelitis (EAE) susceptibility in Drak2(-/-) mice.

Main Results:

  • Drak2(-/-) T cells did not show defects in apoptosis or negative selection.
  • T cells from Drak2(-/-) mice exhibited heightened sensitivity to TCR stimulation, requiring less costimulation.
  • DRAK2 negatively regulates signals through the TCR, thereby raising the T cell activation threshold.
  • Drak2(-/-) mice demonstrated remarkable resistance to EAE compared to control models.

Conclusions:

  • DRAK2 plays a crucial role in negatively regulating T cell activation thresholds.
  • The absence of DRAK2 leads to enhanced T cell sensitivity and resistance to experimental autoimmune encephalomyelitis.
  • These findings reveal a novel pathway governing T cell activation and its implications in autoimmune diseases.

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...